Evidence map›Paper›PMID 27941126›Full record

ArticleGenetics2017

Evolution of Resistance Against CRISPR/Cas9 Gene Drive.

Robert L Unckless, Andrew G Clark, Philipp W Messer

Abstract read
In one paragraph

Article in Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 151 papers.

0numbers the graph read from it
0cells of the map it votes in
151citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

151 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Mapping Gene Drive Dynamics onto Mendelian Models.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

91 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Robert L UncklessDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045.ORCID 0000-0001-8586-7137
Andrew G ClarkDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, New York 14853.
Philipp W MesserDepartment of Biological Statistics and Computational Biology, Cornell University, Ithaca, New York 14853 messer@cornell.edu.ORCID 0000-0001-8453-9377

Funding

Molecular Evolution of Drosophila Y ChromosomeR01GM064590 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI CARVALHO, ANTONIO BERNARDO, CLARK, ANDREW G · 2002 to 2012
$2.0M
Antimicrobial peptides as models for the evolution of gene duplicationR00GM114714 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI UNCKLESS, ROBERT L · 2016 to 2018
$732k
Antimicrobial peptides as models for the evolution of gene duplicationK99GM114714 · NIGMS · CORNELL UNIVERSITY · PI UNCKLESS, ROBERT L · 2015 to 2015
$90k
NIGMS NIH HHS K99 GM114714NIGMS NIH HHS R00 GM114714NIGMS NIH HHS R01 GM064590
6 · The paper itself

Abstract

CRISPR/Cas9 gene drive (CGD) promises to be a highly adaptable approach for spreading genetically engineered alleles throughout a species, even if those alleles impair reproductive success. CGD has been shown to be effective in laboratory crosses of insects, yet it remains unclear to what extent potential resistance mechanisms will affect the dynamics of this process in large natural populations. Here we develop a comprehensive population genetic framework for modeling CGD dynamics, which incorporates potential resistance mechanisms as well as random genetic drift. Using this framework, we calculate the probability that resistance against CGD evolves from standing genetic variation, de novo mutation of wild-type alleles, or cleavage repair by nonhomologous end joining (NHEJ)-a likely by-product of CGD itself. We show that resistance to standard CGD approaches should evolve almost inevitably in most natural populations, unless repair of CGD-induced cleavage via NHEJ can be effectively suppressed, or resistance costs are on par with those of the driver. The key factor determining the probability that resistance evolves is the overall rate at which resistance alleles arise at the population level by mutation or NHEJ. By contrast, the conversion efficiency of the driver, its fitness cost, and its introduction frequency have only minor impact. Our results shed light on strategies that could facilitate the engineering of drivers with lower resistance potential, and motivate the possibility to embrace resistance as a possible mechanism for controlling a CGD approach. This study highlights the need for careful modeling of the population dynamics of CGD prior to the actual release of a driver construct into the wild.

Indexed as

Evolution, MolecularModels, GeneticAnimalsCRISPR-Cas SystemsDNA End-Joining RepairGenetic FitnessCRISPR/Cas9gene drivehoming drivemutagenic chain reactionwhole population replacement

Identifiers

PMID27941126
PMCPMC5289854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.